Clinical Genomics Uppsala

SciLifeLab Infrastructure Unit Since 2014.

Primary: Shown in the list of current labels, if end date is not specified.

Started: 2014

Ended: Current

Year 2025

Year 2024

Year 2023

Year 2022

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Bernard E, Tuechler H, Greenberg PL, ..., Hellström-Lindberg E, Papaemmanuil E
NEJM Evidence 1 (7) - [2022-06-28; online 2022-06-28]
Clinical Genomics [Service] Clinical Genomics Uppsala [Service]

Year 2021

Year 2020

Year 2019

A clonal expression biomarker associates with lung cancer mortality.
Biswas D, Birkbak NJ, Rosenthal R, ..., Swanton C, TRACERx Consortium
Nat. Med. 25 (10) 1540-1548 [2019-10-00; online 2019-10-07]
Clinical Genomics [Collaborative] Clinical Genomics Uppsala [Collaborative]

Year 2018

Year 2017

SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells
Mortera-Blanco T, Dimitriou M, Woll PS, ..., Jacobsen SEW, Hellström-Lindberg E
Blood 130 (7) 881-890 [2017-08-17; online 2017-06-20]
Clinical Genomics [Service] Clinical Genomics Uppsala [Service]

Year 2016

Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond.
Rosenquist R, Rosenwald A, Du MQ, ..., Stamatopoulos K, European Research Initiative on CLL (ERIC) and the European Association for Haematopathology (EAHP)
Haematologica 101 (9) 1002-1009 [2016-09-00; online 2016-09-02]
Clinical Genomics [Collaborative] Clinical Genomics Uppsala [Collaborative]
Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?
Pospisilova S, Sutton LA, Malcikova J, ..., Ghia P, European Research Initiative on CLL (ERIC)
Haematologica 101 (3) 263-265 [2016-03-00; online 2016-03-02]
Clinical Genomics [Service] Clinical Genomics Uppsala [Service]

Year 2015


Publications 9.5.1